Your browser doesn't support javascript.
loading
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy.
Riding, Rebecca L; Richmond, Jillian M; Fukuda, Keitaro; Harris, John E.
Affiliation
  • Riding RL; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Richmond JM; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Fukuda K; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Harris JE; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA, USA.
Pigment Cell Melanoma Res ; 34(4): 683-695, 2021 07.
Article in En | MEDLINE | ID: mdl-33040466
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Melanoma, Experimental / Signal Transduction / Interferon Type I / CD8-Positive T-Lymphocytes / Cross-Priming / Genetic Vectors / Immunotherapy Limits: Animals Language: En Journal: Pigment Cell Melanoma Res Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Melanoma, Experimental / Signal Transduction / Interferon Type I / CD8-Positive T-Lymphocytes / Cross-Priming / Genetic Vectors / Immunotherapy Limits: Animals Language: En Journal: Pigment Cell Melanoma Res Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: United States